Information Links
Mims
Main Navigation
Drugs
Conditions
News and resources
MIMS HostedNew drugs
First oral GLP-1 agonist launched for type II diabetes
Prescribers can now consider a GLP-1 agonist as an...
New rapidly acting insulin launched
Lyumjev is a new 'ultra rapidly acting' formulation...
Transdermal estradiol spray offers new treatment option for HRT
Lenzetto (estradiol) is the first transdermal spray...
Ketamine-derived nasal spray provides new option for resistant depression
Spravato (esketamine) works in a different way to existing...
New e-cigarette alternative launched on prescription
Voke, a new nicotine inhaler, is available to prescribe...
Low-dose oestrogen pessary for vaginal menopause symptoms
Imvaggis (estriol) is a new treatment for vaginal symptoms...
New low-dose oestrogen gel for vaginal menopause symptoms
Blissel is a topical gel containing 50 microgram/g...
Further monthly injectable migraine prophylactic launched
With the launch of Emgality (galcanezumab), prescribers...
New non-oestrogen treatment for vaginal menopause symptoms
Intrarosa (prasterone) is a new topical treatment for...
New migraine prophylactic for monthly or quarterly injection
Fremanezumab (Ajovy) is a monoclonal antibody licensed...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.